SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-057204
Filing Date
2024-05-09
Accepted
2024-05-09 16:51:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 eftr_q1_2024_pro_supp.htm 424B3 1186039
2 GRAPHIC img92196820_0.jpg GRAPHIC 6608
  Complete submission text file 0000950170-24-057204.txt   1196419
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262339 | Film No.: 24931561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)